Rocket Pharmaceuticals Inc (NASDAQ:RCKT) price on Thursday, March 20, fall -1.65% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $8.32.
A look at the stock’s price movement, the close in the last trading session was $8.46, moving within a range at $8.23 and $8.57. The beta value (5-Year monthly) was 1.025. Turning to its 52-week performance, $28.67 and $8.06 were the 52-week high and 52-week low respectively. Overall, RCKT moved -23.81% over the past month.
Rocket Pharmaceuticals Inc’s market cap currently stands at around $887.16 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RCKT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 7 recommend RCKT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RCKT’s current price about -7.29% and -16.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.18, while 7-day volatility ratio is 5.08% and 5.98% in the 30-day chart. Further, Rocket Pharmaceuticals Inc (RCKT) has a beta value of 0.90, and an average true range (ATR) of 0.54. Analysts have given the company’s stock an average 52-week price target of $35.5, forecast between a low of $32 and high of $39. Looking at the price targets, the low is -284.62% off current price level while to achieve the yearly target high, price needs to move -368.75%. Nonetheless, investors will most likely welcome a -326.68% jump to $35.5 which is the analysts’ median price.
If we refocus on Rocket Pharmaceuticals Inc (NASDAQ:RCKT), historical trading data shows that trading volumes averaged 1.43 over the past 10 days and 1.50 million over the past 3 months. The company’s latest data on shares outstanding shows there are 106.45 million shares.
The 7.18% of Rocket Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 101.06% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.04 million on 2025-02-28, giving us a short ratio of 8.52. The data shows that as of 2025-02-28 short interest in Rocket Pharmaceuticals Inc (RCKT) stood at 1886.0 of shares outstanding, with shares short rising to 10.52 million registered in 2025-01-31. Current price change has pushed the stock -33.81% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RCKT stock continues to rise going into the next quarter.
